Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTS: Adjuvant Chemotherapy of Three-step Regimens in Ovarian Cancer
NCT02562365Phase 2Unknown
- Start
- Nov 2015
- Primary completion
- Nov 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, etoposide, carboplatin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC). Status: unknown.
02
Drugs
cyclophosphamideetoposidecarboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02562365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562365.